Showing results (31-40 of 134) with videos related to
Sort By:
Pageof 14
Plos Neglected Tropical Diseases|February 28, 2025
Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohortDavid Wullimann, John Tyler Sandberg, Mira Akber, et al.Plos Pathogens|August 22, 2015
Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 InfectionEdwin Leeansyah, Jenny Svärd, Joana Dias, et al.Journal of Virology|May 1, 2020
Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early InfectionLydia Scharf, Johanna Tauriainen, Marcus Buggert, et al.Journal of Virology|July 5, 2012
Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjectsMelissa M Norström, Marcus Buggert, Johanna Tauriainen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF InhibitorLetizia Gandolfi, Sarah Adamo, Alessandro Pileri, et al.Journal of Clinical Immunology|April 27, 2024
Severe Tick-Borne Encephalitis (TBE) in a Patient with X-Linked Agammaglobulinemia; Treatment with TBE Virus IgG Positive Plasma, Clinical Outcome and T Cell ResponsesWilhelm Hedin, Peter Bergman, Mily Akhirunessa, et al.Plos One|July 14, 2012
Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverageMarcus Buggert, Melissa M Norström, Chris Czarnecki, et al.Frontiers in Immunology|July 28, 2018
Factors Influencing Functional Heterogeneity in Human Mucosa-Associated Invariant T CellsJoana Dias, Caroline Boulouis, Michał J Sobkowiak, et al.AIDS (London, England)|August 16, 2016
CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infectionMarcus Buggert, Juliet Frederiksen, Ole Lund, et al.Journal of Clinical Immunology|May 10, 2022
Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron VariantHannes Lindahl, Jonas Klingström, Rui Da Silva Rodrigues, et al.Pageof 14